Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant

被引:16
|
作者
Haldas, J [1 ]
Wei, WB [1 ]
Lazarchick, J [1 ]
机构
[1] Med Univ S Carolina, Div Haematol & Oncol, Dept Med, Charleston, SC 29403 USA
关键词
PTLD; heart transplantation; T-cell lymphoma; immunosuppression; Epstein-Barr virus;
D O I
10.1080/10428190290006332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Post-transplant lymphoproliferative disorders (PTLD) are a frequently fatal complication occurring after transplant. The majority of cases are of B-cell origin but a smaller percentage of cases are of T-cell origin. The etiology of these disorders is unclear, however, EBV (Epstein-Barr virus) in the context of immunosupperssion is thought to play a role, particularly in B-cell PTLD. We report a case of T-cell PTLD limited to the bone marrow occurring eight years post-cardiac transplantation and review the literature on T-cell PTLD after heart transplant.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 50 条
  • [31] Analysis of the T-cell Receptor Beta Repertoire in Post-Transplant Lymphoproliferative Disorders by Next Generation Sequencing
    Turcotte, Karine
    Zhang, Weiwei
    Schweikart, Courtney
    Aguiar, Roberto Silva
    Greiner, Timothy
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 903 - 903
  • [32] T-cell monomorphic post-transplant lymphoproliferative disorders (T-cell m-PTLD): Clinical characteristics and prognostic assessment of a serious complication after transplant
    Montanari, F.
    Bhagat, G.
    Zain, J. M.
    Seshan, V. E.
    Diefenbach, C. S. Magid
    Clark-Garvey, S.
    McCormick, E.
    Crook, M.
    Conroy, M.
    O'Connor, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Analysis of the T-cell Receptor Beta Repertoire in Post-Transplant Lymphoproliferative Disorders by Next Generation Sequencing
    Turcotte, Karine
    Zhang, Weiwei
    Schweikart, Courtney
    Aguiar, Roberto Silva
    Greiner, Timothy
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 903 - 903
  • [34] Post-transplant T-CELL levels correlate with infectious complications following cardiac transplantation
    Shah, MB
    Ammisetti, B
    Martin, JE
    Giesting, RM
    Wagoner, L
    Schroeder, TJ
    TRANSPLANTATION, 1999, 67 (09) : S568 - S568
  • [35] THE ROLE OF HLA IN CYTOTOXIC T-CELL IMMUNOTHERAPY OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
    Robertson, Victoria J.
    Thompson, Emily
    Dunn, Paul
    Syme, Lorraine
    Turner, David M.
    Turner, Marc L.
    Wilkie, Gwen M.
    Wilson, David
    Dyer, Philip A.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 260 - 260
  • [36] Ocular involvement by T-cell post-transplant lymphoproliferative disorder of cutaneous origin
    Velankar, Milind M.
    Kini, Ameet R.
    PATHOLOGY, 2007, 39 (03) : 369 - U23
  • [37] The role of HLA in cytotoxic T-cell immunotherapy of post-transplant lymphoproliferative disease
    Robertson, V. J.
    Thompson, E.
    Dunn, P.
    Syme, L.
    Turner, D. M.
    Turner, M. L.
    Wilkie, G.
    Wilson, D.
    Dyer, P. A.
    TISSUE ANTIGENS, 2011, 77 (05): : 444 - 445
  • [38] Primary cutaneous T-cell lymphoma post-transplant: an unknown quantity
    Meeajun, B.
    Rizvi, H.
    Harwood, C.
    McGregor, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 : 140 - 140
  • [39] An overview of the pathogenesis and natural history of post-transplant T-cell lymphoma
    Jamali, Faek R.
    Otrock, Zaher K.
    Soweid, Assaad M.
    Al-Awar, Ghassan N.
    Mahfouz, Rami A.
    Haidar, Ghassan R.
    Bazarbachi, Ali
    LEUKEMIA & LYMPHOMA, 2007, 48 (06) : 1237 - 1241
  • [40] Therapeutic options in post-transplant lymphoproliferative disorders
    Zimmermann, Heiner
    Trappe, Ralf Ulrich
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (06) : 393 - 407